HOXD9 regulated mitophagy to promote endothelial progenitor cells angiogenesis and deep vein thrombosis recanalization and resolution
Authors:
Open Access
- 12 June 2024
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-11
Abstract
Background: Deep vein thrombosis (DVT) is a common vascular surgical disease caused by the coagulation of blood in the deep veins, and predominantly occur in the lower limbs. Endothelial progenitor cells (EPCs) are multi-functional stem cells, which are precursors of vascular endothelial cells. EPCs have gradually evolved into a promising treatment strategy for promoting deep vein thrombus dissolution and recanalization through the stimulation of various physical and chemical factors. Methods: In this study, we utilized a mouse DVT model and performed several experiments including qRT-PCR, Western blot, tube formation, wound healing, Transwell assay, immunofluorescence, flow cytometry analysis, and immunoprecipitation to investigate the role of HOXD9 in the function of EPCs cells. The therapeutic effect of EPCs overexpressing HOXD9 on the DVT model and its mechanism were also explored. Results: Overexpression of HOXD9 significantly enhanced the angiogenesis and migration abilities of EPCs, while inhibiting cell apoptosis. Additionally, results indicated that HOXD9 specifically targeted the HRD1 promoter region and regulated the downstream PINK1-mediated mitophagy. Interestingly, intravenous injection of EPCs overexpressing HOXD9 into mice promoted thrombus dissolution and recanalization, significantly decreasing venous thrombosis. Conclusions: The findings of this study reveal that HOXD9 plays a pivotal role in stimulating vascular formation in endothelial progenitor cells, indicating its potential as a therapeutic target for DVT management. GraphicalKeywords
This publication has 45 references indexed in Scilit:
- Endothelial α1‐adrenoceptors regulate neo‐angiogenesisBritish Journal of Pharmacology, 2008
- Endothelial progenitor cells as a new agent contributing to vascular repairArchivum Immunologiae et Therapiae Experimentalis, 2007
- Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancerBreast Cancer Research and Treatment, 2007
- Transplantation of Endothelial Progenitor Cells Transferred by Vascular Endothelial Growth Factor Gene for Vascular Regeneration of Ischemic FlapsJournal of Surgical Research, 2006
- Incidence and Prevalence of Chronic Thromboembolic Pulmonary Hypertension: From Acute to Chronic Pulmonary EmbolismProceedings of the American Thoracic Society, 2006
- Selective Mitochondrial Autophagy, or Mitophagy, as a Targeted Defense Against Oxidative Stress, Mitochondrial Dysfunction, and AgingRejuvenation Research, 2005
- Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2000
- Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Neovascularization during venous thrombosis organization: A preliminary studyJournal of Vascular Surgery, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997